Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Filter Content:
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Interactive Content
Oncology
5 Jan 2026
Managing Eye-Related Adverse Events
Some cancer medicines may cause problems with the eyes or with vision. In this short video, ophthalmologist Dr Neel Pasricha shares his…
Microbiology & Infectious Diseases
30 Oct 2025
Role of Post-Exposure Prophylaxis in COVID-19
Hospitalizations due to COVID-19 have declined, but SARS-CoV-2 transmission remains high in high-exposure settings and…
Oncology
1
Mins
20 Oct 2025
Unmet Need in 1L HR+/HER2- Advanced Breast Cancer
Explore why outcomes often decline after first-line endocrine therapy in HR+/HER2- advanced breast cancer and how emerging treatments…
Oncology
1
Mins
13 Oct 2025
Paradigm Shift in ESR1 Testing: Spot Resistance Earlier
Explore ESR1 mutations in HR-positive breast cancer and how early ctDNA monitoring may help delay endocrine resistance…
Respiratory
23 Sep 2025
IL-5 in Focus: A New View on Type 2 Inflammation
This interactive infographic explores how IL-5 contributes to Type 2 inflammation in severe asthma. Discover IL-5’s effects on immune cells beyond eosinophils, and the clinical consequences.
Oncology
11 Sep 2025
An FDA Approval for Certain Patients with Endometrial Cancer
Neurology
10 Sep 2025
Alzheimer’s Diagnosis Dilemma: How Do You Confirm the Presence of Amyloid?
When evaluating patients with cognitive impairment, early confirmation of amyloid can change the course of care, yet the tools to do so…
Dermatology
21 Jul 2025
Type 2 Inflammation in Pediatric Diseases
Uncover how multiple pediatric atopic diseases have a shared Type 2 inflammatory profile…
Dermatology
24 Jun 2025
Explore the Mechanism of Action and 5-Year Data of Deucravacitinib
Learn about the mechanism of action and latest clinical safety and efficacy data of deucravacitinib.
Dermatology
7 Mar 2025
Can Pediatric AD Disease Course Be Changed?
Join experts Amy Paller and Peter Lio for this interactive learning experience.
Rheumatology
5 Feb 2026
The first and only approved dual inhibitor of IL-17A and IL-17F1-6
BIMZELX® Demonstrated Deep and Sustained Efficacy to 3 Years Across Multiple Disease Domains of PsA and the Full axSpA Spectrum…
Respiratory
30 Jan 2026
Putting the Pieces Together: A Patient-Centred Approach to Bronchiectasis Diagnosis
Putting the Pieces Together: A Patient-Centred Approach to Bronchiectasis Diagnosis…
Nephrology
23 Jan 2026
Targeting Endothelin and Angiotensin in IgA Nephropathy
Endothelin-1 (ET-1) and angiotensin II (Ang II) overexpression is recognised as a mediator of disease progression in immunoglobulin…
Oncology
23 Dec 2025
Exploring the Role of Molecular Profiling: Using NGS in the Diagnosis and Treatment of Biliary Tract Cancers (BTC)
In this webinar, clinical experts discuss how next-generation sequencing (NGS) can guide targeted treatment in biliary tract cancers…
Dermatology
22 Dec 2025
Navigating Head and Neck Atopic Dermatitis
This ICS highlights key symptoms, diagnostic features, and evolving treatment approaches, including the use of tralokinumab…
Nephrology
19 Dec 2025
IgA Nephropathy Treatment 2025
These are hypothetical patient cases and outcomes may not be reflective of clinical studies or real-life circumstances. The mention of…
Neurology
14 Oct 2025
Identifying Appropriate Patients for Migraine Treatment
Explore clinical assessments and range of management options for a hypothetical patient who is experiencing frequent migraine attacks…
Allergy & Immunology
2 Oct 2025
Allergic Rhinitis in Children: The School Environment
Allergens, allergic rhinitis (AR), allergy, allergy-friendly schools, antihistamines, asthma, nasal corticosteroids, non-sedating...
Neurology
25 Sep 2025
PERMIT Study: Perampanel as Early Add-On
Epilepsy is a common neurological condition that results from abnormal electrical activity in the brain and is characterised by recurrent…
Gastroenterology
24 Sep 2025
Understanding the Challenges of Primary Biliary Cholangitis
Explore a patient case study of a 45-year-old patient diagnosed with primary biliary cholangitis (PBC). Navigate the patient’s medical history discover the key symptoms.
Respiratory
18 Sep 2025
COPD Has Many Faces
Case study of a 59-year-old COPD patient with emphysema, showing disease presentation, progression, exacerbation, and improved outcomes after tailored treatment.
Gastroenterology
17 Sep 2025
Advancing Liver Care with ESSENTIALE
Unlock expert insights into the evolving landscape of liver health with this interactive symposium video. Focused on the role of…
Allergy & Immunology
16 Sep 2025
Effectiveness of Berotralstat▼ for Hereditary Angioedema Prophylaxis
What does effective prophylaxis look like for people living with hereditary angioedema (HAE)? In this new interactive article, two leading…
Dermatology
12 Sep 2025
The POSITIVE Phase IV Study: Interim 52-Week Results on Patient Well-Being With Tildrakizumab
Psoriatic disease extends beyond the skin, imposing a significant psychosocial burden, often leading to embarrassment, social withdrawal…
Loading posts...
« Previous
1
2
3
4
5
…
8
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View